Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 23, 2017 | ADC Therapeutics | $200.0M Other Equity | AstraZeneca, Auven Therapeutics, Redmile Group, Wild Family Office | — |
| Oct 27, 2016 | ADC Therapeutics | $105.0M Other Equity | — | AstraZeneca, Peter Corr, Wild Family Office |
| Sep 2, 2015 | ADC Therapeutics | $80.0M Other Equity | — | AstraZeneca, Peter Corr |
| Oct 15, 2013 | ADC Therapeutics | $40.0M Other Equity | Michael Forer, Bahija Jallal | — |
| Jan 20, 2010 | Kolltan Pharmaceuticals | $10.0M Other Equity / Series B | Auven Therapeutics | Tichenor Ventures |